Avantium N.V. (NL:AVTX)
:AVTX
Want to see NL:AVTX full AI Analyst Report?
Top Page
Avantium N.V.
(AVTX)
Select Model
Select Model
Rating:46Neutral
Price Target:
€7.00
▼(-0.71% Downside)
Action:ReiteratedDate:03/21/26
The score is held back primarily by weak financial performance (persistent losses, negative gross profit, and ongoing cash burn despite some improvement in 2025). Technicals add pressure with the stock trading below key moving averages and a negative MACD, while valuation is only modestly supportive because the negative P/E reflects continued unprofitability and no dividend yield is provided.
Positive Factors
Proprietary technology and IP
Avantium's ownership of proprietary catalytic and process technologies for FDCA and PEF creates a durable competitive moat. IP-led chemistry enables licensing and tech services revenue with lower incremental capital intensity than pure manufacturing, supporting scalable margins as partners commercialize the tech.
Negative Factors
Structural unprofitability
The company reports negative gross profits and recurring operating and net losses, indicating that costs exceed revenue at present. This structural unprofitability undermines the ability to fund growth internally and heightens reliance on outside capital, delaying a sustainable path to positive margins.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary technology and IP
Avantium's ownership of proprietary catalytic and process technologies for FDCA and PEF creates a durable competitive moat. IP-led chemistry enables licensing and tech services revenue with lower incremental capital intensity than pure manufacturing, supporting scalable margins as partners commercialize the tech.
Read all positive factors
Avantium N.V. (AVTX) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€184.01M
Dividend YieldN/A
Average Volume (3M)515.06K
Price to Earnings (P/E)―
Beta (1Y)1.45
Revenue Growth-30.63%
EPS Growth43.45%
CountryNL
Employees284
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.62
Shares Outstanding25,206,718
10 Day Avg. Volume262,999
30 Day Avg. Volume515,059
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.60
Price to Sales (P/S)6.22
P/FCF Ratio-1.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.40Price Target Upside-9.22% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.17
Revenue Forecast (FY)€43.19M
Avantium N.V. Business Overview & Revenue Model
Company Description
Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Pol...
How the Company Makes Money
Avantium makes money primarily through (1) commercialization of its renewable chemistry technologies and (2) providing related development services, with revenue generally arising from a mix of technology-based income and product-based income as i...
Avantium N.V. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 14.59M | 21.04M | 19.70M | 17.83M | 10.92M |
| Gross Profit | -34.38M | -30.57M | -25.30M | -24.55M | -25.37M |
| EBITDA | -39.47M | -24.52M | -25.78M | -19.59M | -16.09M |
| Net Income | -22.52M | -26.87M | -31.40M | -28.13M | -24.42M |
Balance Sheet | |||||
| Total Assets | 356.17M | 288.63M | 228.49M | 163.58M | 77.67M |
| Cash, Cash Equivalents and Short-Term Investments | 57.47M | 23.90M | 35.22M | 64.87M | 34.91M |
| Total Debt | 165.06M | 151.59M | 108.82M | 24.59M | 10.70M |
| Total Liabilities | 206.57M | 190.84M | 174.62M | 70.56M | 27.65M |
| Stockholders Equity | 152.52M | 95.85M | 46.17M | 82.58M | 50.03M |
Cash Flow | |||||
| Free Cash Flow | -58.54M | -103.39M | -108.14M | -45.12M | -16.54M |
| Operating Cash Flow | -37.89M | -45.06M | -18.82M | -11.17M | -12.61M |
| Investing Cash Flow | -20.66M | -58.63M | -89.77M | -33.95M | -3.93M |
| Financing Cash Flow | 92.11M | 83.36M | 78.94M | 75.08M | 24.83M |
Avantium N.V. Technical Analysis
Positive
7.05
Price Trends
6.65
Positive
6.70
Positive
7.40
Positive
Market Momentum
0.19
Negative
75.44
Negative
69.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AVTX, the sentiment is Positive. The current price of 7.05 is above the 20-day moving average (MA) of 6.79, above the 50-day MA of 6.65, and below the 200-day MA of 7.40, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 75.44 is Negative, neither overbought nor oversold. The STOCH value of 69.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:AVTX.
Avantium N.V. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | €77.00M | 10.66 | 7.37% | 7.70% | 4.14% | -29.16% | |
64 Neutral | €5.69B | 20.99 | 10.83% | 2.83% | 1.08% | -24.24% | |
59 Neutral | €1.06B | 14.40 | 8.84% | 3.50% | -1.61% | 38.58% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €766.03M | ― | ― | 229.25% | ― | ― | |
49 Neutral | €1.14B | -5.46 | 6.84% | 1.46% | 13.55% | 50.22% | |
46 Neutral | €184.01M | -4.03 | -26.08% | ― | -30.63% | 43.45% |
* General Sector Average
NL:AVTX
Avantium N.V.
7.30
1.73
31.01%
NL:AMG
AMG ADVANCED METALLURGICAL GROUP NV
35.18
19.69
127.17%
NL:CRBN
Corbion NV
18.49
0.46
2.55%
NL:HOLCO
Holland Colours N.V.
89.50
5.80
6.93%
NL:IMCD
IMCD N.V.
96.38
-18.47
-16.08%
NL:OCI
OCI N.V.
3.63
-1.01
-21.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.